"Hi Jake, He said it makes things “more intense” when I’m squirming and trying not to go, and that the idea of me finally ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Pfizer Inc. today announced positive results from the pivotal Phase 3 EV-303 clinical trial (also known as ...

Abu Dhabi: A complex fetoscopic surgery to repair spina bifida was successfully conducted at SEHA Sheikh Khalifa Medical City ...

Group sales In the first nine months of 2025, Roche achieved sales growth of 7% (2% in CHF) to CHF 45.9 billion due to strong demand for our pharmaceutical and diagnostic products.

Johnson & Johnson JNJ delivered strong third-quarter 2025 results, with both the top and bottom lines exceeding expectations.

Identifying biomarkers that simultaneously reflect inflammation and coagulation status is crucial for early prediction and prevention of VTE in high-risk populations.

This is the first meta-analysis comparing the overall survival of patients with limited-stage small cell bladder cancer who underwent radical surgery with platinum-based perioperative chemotherapy vs ...

() -Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...

Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...

Discover a study on SIP-BMG for bladder neck stenosis, revealing over 90% success and lasting improvements in urinary ...

FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that it has entered into a ...